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Embryonic Hedgehog signaling is essential for proper tissue morphogenesis and organ formation along the developing gastrointestinal
tract. Hedgehog ligands are expressed throughout the endodermal epithelium at early embryonic stages but excluded from the region that will
form the pancreas. Ectopic activation of Hedgehog signaling at the onset of pancreas development has been shown to inhibit organ
morphogenesis. In contrast, Hedgehog signaling components are found within pancreatic tissue during subsequent stages of development as
well as in the mature organ, indicating that a certain level of pathway activation is required for normal organ development and function. Here,
we ectopically activate the Hedgehog pathway midway through pancreas development via expression of either Sonic (Shh) or Indian
Hedgehog (Ihh) under control of the human Pax4-promoter. Similar pancreatic defects are observed in both Pax4-Shh and Pax4-Ihh
transgenic lines, suggesting that regulation of the overall level of Hedgehog activity is critical for proper pancreas development. We also
show that Hedgehog signaling controls mesenchymal vs. epithelial tissue differentiation and that pathway activation impairs formation of
epithelial progenitors. Thus, tight control of Hedgehog pathway activity throughout embryonic development ensures proper pancreas
organogenesis.
D 2005 Elsevier Inc. All rights reserved.
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The pancreas is an endodermal organ that produces
digestive enzymes and regulatory hormones required to
control blood glucose homeostasis. Exocrine cells secrete
digestive enzymes that are released into the duodenum via
an extensive, interconnected ductal system. The hormone-
releasing endocrine cells are clustered in islets of Langer-
hans, epithelial-derived cells dispersed throughout the
exocrine matrix (Slack, 1995). During embryogenesis, the
pancreas develops from the epithelial cells of the embryonic
gut endoderm at the foregut–midgut junction, and organ
development in this region is regulated by the activity of the
Hedgehog signaling pathway. Hedgehog molecules are
secreted proteins that induce concentration-dependent
responses in target cells, thereby regulating cell growth
and differentiation in a wide variety of embryonic tissues0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: mhebrok@diabetes.ucsf.edu (M. Hebrok).(Ingham and McMahon, 2001). Three secreted hedgehog
ligands, Sonic (Shh), Indian (Ihh), and Desert hedgehog
(Dhh), have been identified in mammals. In target cells, all
three Hedgehog proteins bind to the 12-transmembrane
protein receptor Patched (Ptch), an interaction that de-
represses Ptch inhibition of Smoothed (Smo), another
transmembrane protein. Smo activation leads to nuclear
translocation of the transcription factor Gli and subsequent
expression of Hedgehog target genes, including Ptch and
Gli itself, as well as Hhip, a Hedgehog binding protein
known to attenuate ligand diffusion (Chuang and McMa-
hon, 1999). Thus, the pathway is tightly controlled through
a negative feedback loop in which activation results in
production of Hhip and Ptch proteins that function to limit
Hedgehog signaling.
Within the developing pancreas anlage, Hedgehog path-
way is active in stomach and duodenum but suppressed in
pancreatic tissue (Ahlgren et al., 1997; Apelqvist et al.,
1997; Hebrok et al., 1998). This clear demarcation of
Hedgehog activity generates a sharp molecular boundary280 (2005) 111–121
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of the embryonic gut tube. Recent studies analyzing
pancreas formation in mice carrying targeted deletions of
the Hedgehog inhibitors Ptch and Hhip demonstrate
increasingly severe defects in pancreatic morphogenesis in
direct correlation to reduction of the Hedgehog signaling
antagonists (Kawahira et al., 2003). These results suggest
that even moderate activation of the Hedgehog pathway at
the onset of pancreas formation compromises organo-
genesis. In contrast, studies on cultured insulinoma cells
had indicated that Hedgehog activity is required for insulin
expression and secretion, suggesting a requirement for the
pathway in more mature tissue (Thomas et al., 2000, 2001).
Here, we provide evidence that ectopic activation of the
Hedgehog pathway at a stage when organ boundaries have
formed and pancreas morphogenesis has been initiated is
sufficient to severely disrupt organ architecture. Expression
of either Shh or Ihh ligands under control of a previously
characterized human Pax4 promoter element (Smith et al.,
2000) results in significant reduction in pancreatic acinar
and epithelial cells, including ngn3-positive endocrine
precursors. Pancreas and islet mass are significantly reduced
at the end of gestation and the proliferative capacity of
developing h-cells is impaired in Pax4-Hedgehog (Pax4-
Hh) transgenic embryos. Immunohistochemistry against
Hedgehog target genes reveals that both epithelial and
mesenchymal cells respond to Hedgehog ligands, suggest-
ing autocrine and paracrine pathway activation. Interest-
ingly, pancreatic defects are almost identical in Pax4-Shh
and Pax4-Ihh mice, strongly suggesting that the overall
level of Hedgehog activity rather than the expression of
individual ligands controls pancreas organogenesis.Materials and methods
Mice
Mice used in these studies were maintained in the barrier
facility according to protocols approved by the Committee
on Animal Research at the University of California, San
Francisco. Transient Pax4-Shh transgenic founders were
crossed with C57BL/6 wild type mice to generate one stable
line. Transient Pax4-Ihh transgenic mice were mated with
FVB/N wild type mice to generate three independent stable
lines.
Transgenic constructs
The human Pax4 gene was obtained from human cosmid
clone g1572c264, and the sequence between 4958 bp and
+46 bp relative to the transcription start site was used in the
generation of the transgenic mice (Smith et al., 2000). The
human Pax4 promoter was cloned into the KpnI/XhoI sites
upstream of the b-galactosidase gene in the plasmid phgal-
Enhancer (CLONTECH). A 1314 bp mouse cDNA encod-ing Shh was cloned into the XhoI/EcoRV sites and a 1011
bp mouse cDNA encoding Ihh was cloned into the XhoI/
SplI sites in the b-galactosidase gene.
Tissue preparation, immunohistochemistry, and microscopy
The lower trunk of E15.5 (embryonic day 15.5) embryos
or pancreata isolated from E18.5 embryos were fixed in 4%
(w/v) paraformaldehyde (PFA) in phosphate-buffered saline
(PBS) for 1 to 4 h at 48C. Histological analysis,
quantification of the tissue area, and counting of cells, were
performed as previously described (Hebrok et al., 2000).
Hematoxilin/Eosin staining and immunofluorescence anal-
yses were performed on paraffin sections as described
previously (Kim et al., 1997). The following primary
antibodies were used: guinea pig anti-insulin diluted 1:500
(Linco); rabbit anti-glucagon diluted 1:500 (Linco); mouse
E-Cadherin diluted 1:200 (BD Biosciences); rabbit Pdx-1
diluted 1:3000 (antibody was raised against the carboxy
terminus of mouse Pdx-1) (Schwitzgebel et al., 2000);
hamster anti-mucin1 diluted 1:200 (NeoMarkers); rabbit
anti-amylase diluted 1:750 (Sigma); mouse Cy3-conjugated
anti-a-smooth muscle actin diluted 1:200 (Sigma); mouse
anti-Vimentin diluted 1:200 (Sigma); rabbit anti-Ki-67
diluted 1:200 (Novocastra Laboratories Ltd.); Rabbit anti-
Nkx6.1 diluted 1:3000 (antibody was raised against a GST
fusion protein containing the carboxy-terminal 70 amino
acids of hamster Nkx6.1) (Sussel et al., 1998); Rabbit anti-
neurogenin3 (antibody was raised against a GST fusion
protein containing the amino-terminal 95 amino acids of
mouse neurogenin3) (Schwitzgebel et al., 2000) diluted
1:1000; Goat anti-Shh (N-19, SantaCruz, Cat#SC-1194,
Lot# F262) diluted 1:10; Goat anti-Ihh (C-15, SantaCruz,
Cat#SC-1196, Lot# K060) diluted 1:10; and Goat anti-Ptch
(G-19, SantaCruz, Cat#SC-6149, Lot# E142) diluted 1:10.
For immunohistochemistry, the biotinylated anti-Goat
IgG (Vector) was used as secondary antibodies at a 1:200
dilution. Staining for diaminobenzidine (DAB) was per-
formed with the ABC Elite immunoperoxidase system
(Vector). The following secondary antibodies were used
for immunofluorescence: FITC-conjugated anti-guinea pig
1:750, FITC-conjugated anti-rabbit 1:750 (Molecular
Probes), FITC-conjugated anti-hamster 1:200 (Jackson
ImmunoResearch), Cy3-conjugated anti-rabbit diluted
1:750, Cy3-conjugated anti-guinea pig diluted 1:750, and
Alexa FluorR 568 conjugated anti-mouse diluted 1:200
(Molecular Probes). DAB expression and fluorescence were
visualized and photographed with a Zeiss Axiphoto2 plus
microscope.
Whole mount in situ hybridization
Gastrointestinal tracts, including stomach, pancreas, and
duodenum, of E12.5, E13.0, and E13.5 wild type as well as
Pax4-Shh and Pax4-Ihh embryos were dissected and fixed
in 4% PFA overnight at 48C. Whole mount in situ
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probe were performed as previously described (Chuang et
al., 2003). Stained tissues were photographed on a Leica
MZ FL3 equipped with a Leica IM500 system.
RNA preparation and RT-PCR analysis
Dissected E15.5 embryonic pancreata were dissolved in
Trizol (Gibco-BRL) and total RNA was prepared according
to the manufacturer’s methods. First-strand cDNA was
prepared using the SensiscriptR RT kit (QIAGEN) and
random hexamer primers (Invitrogen) in a total volume of 50
Al according to the manufacturer’s instructions. 1 Al of the
cDNA product was used as a template and ngn3 PCR was
performed under the following conditions: 1 cycle of 948C
for 30 s; 608C for 1 min; 728C for 1.5 min followed by 35
cycles of 948C for 1 min and 728C for 7 min for extension.
Mouse b-actin was used as the internal control. Forward and
reverse primer sequences used are listed 5V to 3V.
Ngn3; CGCACCATGGCGCCTCATCCCTTGG and
CAGAGGATCCTCTTCACAAGAAGTCTGAG
b-actin ; ATGACGATATCGCTGCGCTGGT and
ATAGGAGTCCTTCTGACCCATTCC.
SYBR Green real-time quantitative PCR
Real-time PCR analysis was performed as described
previously (Kawahira et al., 2003).
Morphometric quantification of pancreatic tissues and cell
counting
To obtain representative results, an aliquot of the whole
pancreas was used for quantification. The first five consec-
utive sections (6 Am) of E15.5 or E18.5 pancreatic tissue,
respectively, were mounted on the first of a series of five
microscope slides, followed by the next five sections placed
on the second slide. A total of five individual slides (1a–5a)
were prepared from E15.5 or E18.5 specimens. When
necessary, additional series of five slides (1b–5b, etc.) were
prepared until all pancreatic sections were mounted.
After hematoxilin/eosin staining or immunohistochemis-
try, pancreatic epithelial areas were outlined and quantified
with the OpenLab software. Epithelial area refers to
pancreatic ducts, endocrine and exocrine area. Mesenchyme
area was obtained by subtracting the epithelial area from the
total pancreatic area. Insulin- and glucagon-positive areas of
the E18.5 pancreas were measured on every 25th sections
(every 150 Am) from one set of slides (1a–1e). All Ki-67/
insulin double-, Ngn3-, insulin-, or glucagon-positive cells
were counted using one series of the slides prepared from
E15.5 or E18.5 pancreatic tissue. Data analysis was
performed with Microsoft Excel (Microsoft). Statistical
significance was assessed by employing Student’s t test.
Error bars are shown as FSD.Results
Ectopic activation of Hedgehog signaling in Pax4-Shh and
Pax4-Ihh transgenic mice
Here, we decided to test whether ectopic activation of
the Hedgehog pathway midway through pancreas devel-
opment impairs organ formation. To address this question,
we ectopically expressed Shh and Ihh under control of
the human Pax4 promoter. The Pax4 promoter element is
well characterized and has previously been used to
control expression of the bacterial LacZ gene in
pancreatic tissue in transgenic mice (Smith et al., 2000).
These studies revealed strong h-galactosidase activity
throughout the developing pancreatic epithelium starting
at embryonic day 12.5 of gestation (E12.5). Over time,
the activity of the human promoter element becomes
mainly restricted to the differentiated h-cells and persists
in fully matured islets, contrary to the murine promoter
which loses its activity in mature h-cells (Smith et al.,
2000).
In situ hybridizations against Shh mRNA were per-
formed to test if the activity of the Pax4-promoter is
sufficient to markedly induce expression of Hedgehog
ligands in pancreatic epithelium and to confirm that target
genes are activated during the secondary transition, a time
period when mature h-cells are generated. Expression of
Shh was neither detected in wild type pancreas at E13.5 nor
in Pax4-Shh transgenic pancreas at E12.5 (Fig. 1). In
contrast, we observed strong Shh expression in Pax4-Shh
transgenic pancreatic tissue at E13.5 (Figs. 1C, D). To
further define the exact onset of transgene expression, and
to confirm transgene activation in both Pax4-Hh lines, we
performed whole mount in situ hybridization of timed
E12.5 and E13.0 wild type and Pax4Ihh embryos. In
support of previous reports (Hebrok et al., 2000), in situ
hybridization failed to detect expression of Ihh mRNA in
wild type pancreata at the stages analyzed. While no
expression of Ihh was found in E12.5 Pax4Ihh pancreas, a
clear signal was observed in pancreatic tissue at E13.0 in
Pax4Ihh embryos (Figs. 1M, N). As expected, no morpho-
logical changes were observed in pancreatic tissues isolated
from Pax4-Hh embryos before or at the onset of Pax4
promoter mediated Hedgehog ligand expression (Supple-
mentary Fig. 1).
To quantitatively determine the level of Hedgehog
activation in Pax4-Shh and Pax4-Ihh pancreata, we
performed real-time PCR analysis of Gli1 expression, a
transcriptional target gene of Hedgehog signaling. Gli1
levels were significantly increased in both of Pax4-Shh
(~13-fold) and Pax4-Ihh (~14-fold) mice when compared
to wild type littermates (Fig. 1Q). Therefore, ectopic
expression of either Shh or Ihh under control of a human
Pax4 promoter element results in significant increases in
Hedgehog signaling after organ boundaries have been
established.
Fig. 1. The human Pax4-promoter induces Hedgehog ligand expression midway through pancreas development. Shh is normally absent from the developing
pancreas and was not detected in either E12.5 Pax4-Shh transgenic or E13.5 wild type (wt) pancreatic tissue by in situ hybridization (A, B, E, F). In contrast,
expression of the ligand was observed in Pax4-Shh pancreas at E13.5 (C, D). Expression of Ihh transcripts are not detected in either E12.5 Pax4-Ihh transgenic
or E13.0 wild type (wt) pancreatic tissue (G–L). Expression of the ligand was observed in Pax4-Ihh pancreas at E13.0 (M, N). Real-time PCR analysis revealed
that expression of Gli1, a transcriptional target of Hedgehog signaling, is significantly up-regulated in both of Pax4-Shh and Pax4-Ihh pancreata at E15.5 (Q).
Blue bar; control, n = 4; red bar, Pax4-Shh, n = 4; yellow bar; Pax4-Ihh, n = 4. Error bars are shown as SD. #Statistically insignificant differences; TTP b 0.01.
dp, dorsal pancreas; vp, ventral pancreas. Red dotted line indicates pancreas and yellow arrowhead marks Shh or Ihh expression. as, anti-sense riboprobe; s,
sense riboprobe (O, P).
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morphogenesis
Ectopic expression of Shh at the onset of pancreas
organogenesis severely impairs organ morphogenesis and
results in transformation of pancreatic cells into duodenal
tissue (Apelqvist et al., 1997). To determine whether Shh or
Ihh expression at later stage causes defects in organ gross
morphology, we first examined embryonic pancreas at
E18.5. While the overall body weights of wild type mice
were indistinguishable from Pax4-Hh transgenic embryos,
pancreas mass in Pax4-Shh and Pax4-Ihh mice was
significantly reduced (Figs. 2A–D). Importantly, defects
were confined to the pancreas proper whereas the adjacent
organs, stomach, spleen, and duodenum, appeared morpho-
logically unaltered. Histological analysis revealed an appa-
rent loss of exocrine tissue concomitant with a significant
increase in non-epithelial tissue (Figs. 2E–G). Morphomet-ric analysis confirmed these observations and showed that
ectopic expression of either Shh or Ihh under control of the
Pax4 promoter results in a dramatic reduction (~90%) in
pancreatic epithelium (Fig. 2H).
Increase in pancreatic mesenchyme and decrease in
pancreatic epithelium upon Hedgehog activation
To investigate the molecular changes in pancreas
morphology and cell differentiation, we performed immu-
nofluorescent staining against mesenchymal (vimentin)
(Gabbiani et al., 1981; Zoltan-Jones et al., 2003), epithelial
and epithelial-derived tissue (E-Cadherin) (Selander and
Edlund, 2002), acinar (amylase), and ductal/centroacinar
markers (mucin-1) at E18.5 (Fig. 3). While abundant at
earlier stages, only a few vimentin-positive mesenchymal
cells were found in the vicinity of mucin-1-positive duct
cells in wild type controls (Fig. 3A). In contrast, we detected
Fig. 2. Ectopic expression of Hedgehog ligands under control of the Pax4-promoter controls pancreas morphogenesis. Macroscopic analysis of E18.5 pancreata
(A–C) shows a significant reduction in overall pancreas mass while adjacent organs are unaffected. Body weights of wild type or transgenic embryos were
similar; however, the relative pancreas size in both the Pax4-Shh and Pax4-Ihh were significantly reduced by 46.5% and 34.9%, respectively (D). Blue bars,
control, n = 13; red bars, Pax4-Shh, n = 5; yellow bars, Pax4-Ihh, n = 6. Histological analysis of hematoxylin/eosin staining reveals defects in tissue
organization and reduction in exocrine area (E–G). Morphometric quantification demonstrates a marked 88.5–94.3 reduction in epithelial area (H). Blue bar;
control, n = 10; red bar, Pax4-Shh, n = 7; yellow bar, Pax4-Ihh, n = 5. Error bars are shown as SD. #No statistical difference; TTTP b 0.001. Scale bar is 100
Am (E–G).
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transgenic pancreas (Figs. 3B, C). Ectopic activation of Shh
under control of the Pdx-1 promoter results in efficient
differentiation of pancreatic mesenchyme into duodenal
mesoderm (Apelqvist et al., 1997) and activates expression
of a-smooth muscle actin, a marker of intestinal mesen-
chyme, in the pancreata of Pax4-Shh or Pax4-Ihh transgenic
mice (Figs. 3D–F).
The increase of mesenchymal tissue in Pax4-Hh trans-
genic embryos is accompanied by a reduction of amylase-
positive acinar tissue (Figs. 3D–I). Expression of amylase is
lost from the central portions of the pancreas (Figs. 3E, F,
H, I) and only a few areas with well-differentiated acinar
structures remain (Figs. 2F, G). Similarly, the architecture
of the ductal system is impaired in Pax4-Hh embryos. The
few remaining ducts appeared dilated in pancreata of both
Pax4-Shh and Pax4-Ihh embryos (Figs. 3G–I); however,
pathological examination did not indicate neoplastic cell
transformation.
During development, an immature epithelium gives rise
to the mature exocrine and endocrine compartment of the
pancreas (Kim and Hebrok, 2001). In contrast to the
exocrine cells that maintain their epithelial organization,
endocrine cells delineate from the embryonic epithelium
that branches into the overlying mesenchyme. To test
whether epithelial defects are present in Pax4-Hh trans-
genic pancreata, we stained for E-Cadherin, a marker of
epithelial and epithelial-derived endocrine cells, and insu-
lin, a marker for h-cells (Figs. 3J–L). Expression of both
proteins is significantly reduced in transgenic embryos,
indicating that ectopic Hedgehog activation results infailure to form epithelial and epithelial-derived endocrine
cells.
Hedgehog pathway regulates islet morphology and size
To further determine the effect of ectopic Hedgehog
signaling on the development of the endocrine compart-
ment, we tested for changes in islet morphology and h-cell
differentiation. Murine islets are characterized by a well-
defined architecture in which a core of insulin-producing h-
cells are surrounded by other endocrine cell types,
including glucagon-producing a-cells. At E18.5, the time
point when endocrine cells first cluster in wild type
embryos, islet morphology is severely impaired in both
Pax4-Shh and Pax4-Ihh mice (Figs. 4A–C). Endocrine cells
still cluster; however, the average size of the islets is
significantly reduced and approximately 80% of the overall
endocrine area is lost in transgenic mice (Fig. 4J). While
these findings further support an inhibitory effect of
elevated Hedgehog signaling on endocrine cell develop-
ment, the differentiation of the h-cells present in the
transgenic pancreas is unaffected. Insulin-producing cells
appear to differentiate properly and express mature h-cell
markers, including the transcription factors Pdx-1 (Figs.
4D–F) and Nkx6.1 (Figs. 4G–I) as well as the glucose
transporter Glut-2 (data not shown). In contrast, we found
differences in proliferation capacity of normal and trans-
genic h-cells. When compared to controls, only approx-
imately 30–40% of the insulin-producing cells in Pax4-Shh
and Pax4-Ihh mice also stain positive for Ki-67 (Fig. 4K), a
marker for actively proliferating cells. Thus, ectopic
Fig. 3. Pax4-Hh transgenic pancreata are marked by an increase in the mesenchymal and a decrease in the epithelial compartment. The number of vimentin-
positive mesenchymal cells is increased in Pax4-Shh and Pax4-Ihh transgenic pancreata at E18.5 (A–C). a-smooth muscle actin (sma) is detected in Pax4-Shh
and Pax4-Ihh transgenic pancreata at E18.5 (E, F). sma-positive cells in wild type tissue (D) are confined to blood vessels and large pancreatic ducts. Amylase-
positive exocrine cells and mucin-positive duct structures are reduced (G–I). Staining for epithelial (E-cadherin) and epithelial-derived insulin-positive
endocrine cells is shown in J–L. wt, control; PS, Pax4-Shh; PI, Pax4-Ihh. Scale bar is 50 Am.
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phogenesis and expansion of the pool of insulin-producing
h-cells.
Pancreas morphology is impaired in Pax4-Hh transgenic
embryos at E15.5
The Pax4 promoter induces Hedgehog expression
approximately at the time of the secondary transition when
mature h-cells form (Pictet and Rutter, 1972). To test
whether the phenotypes observed at E18.5 result from
defects at earlier stages, we analyzed pancreas development
at E15.5, little over two days after ectopic expression of
Hedgehog ligands is first observed (Figs. 1 and 5). Based on
gross morphology and hematoxylin/eosin staining, pancre-
atic rudiments are smaller in Pax4-Hh transgenic embryos
and histological analysis exposed an increased level of
mesenchymal tissue accompanied by a failure to form
epithelial structures in Pax4-Hh transgenic mice (Figs. 5A–
F). Morphometric quantification confirmed a more than80% reduction of the epithelial area concomitant with a
small but significant increase in mesenchymal tissue (Figs.
5G, K), resulting in an overall reduction of the pancreatic
area. As expected from the analysis of the hematoxylin/
eosin staining, the number of amylase-expressing acinar
cells was reduced as well (Figs. 5H–J). Therefore, increased
Hedgehog levels rapidly augment the size of the mesen-
chymal compartment while inhibiting the expansion and
branching of the epithelial cell layer.
An unresolved question concerns the identity of pancre-
atic cells that respond to Hedgehog signaling. Hedgehog-
responsive cells up-regulate expression of specific target
genes, including Ptch, Hhip, and Gli. Immunohistochemical
analysis of wild type pancreatic tissue revealed epithelial
expression of Ptch. Forced ligand expression under control
of the Pax4 promoter resulted in increased expression of
Ptch in epithelial, epithelial-derived, and mesenchymal cells
(Figs. 5L–N, Supplementary Fig. 2). These results suggest
that Hedgehog signaling regulates pancreatic development
in autocrine and paracrine fashion.
Fig. 4. Impaired islet morphology in Pax4-Hh transgenic embryos. Insulin/glucagon staining reveals reduction in transgenic islet size and change of normal
islet architecture (A–C). Morphometric quantification of islet area results in 87.4% and 80.9% reduction of endocrine area (J). Similarly, a profound 71.1% and
62.6% reduction of Ki-67-positive proliferating cells is observed within insulin-positive cells (K). Differentiation of developing h-cells is unaffected. The
insulin-positive cells that have formed express mature markers, including Pdx-1 (D–F) and Nkx6.1 (G–I). wt; control, PS; Pax4-Shh, and PI; Pax4-Ihh at
E18.5. (J) Blue bar, control, n = 6; red bar, Pax4-Shh, n = 4; yellow bar, Pax4-Ihh, n = 5. (K) Blue bar; control, n = 4, red bar, Pax4-Shh, n = 3, and yellow bar;
Pax4-Ihh, n = 7. Error bars are shown as SD. #No statistical difference; TTP b 0.01; TTTP b 0.001. Scale bar is 50 Am.
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tissue
The apparent loss of epithelial cells prompted us to
investigate the number of endocrine progenitor and differ-
entiated endocrine cells in Pax4-Hh transgenic mice. To test
the development of endocrine cells at E15.5, we examined
insulin, glucagon and ngn3 expression. While glucagon-
and insulin-positive cell clusters were found in transgenic
mice, the size of the cell aggregates is reduced and the
number of insulin/glucagon-expressing cells is decreased
(Figs. 6A–D). In Pax4-Hh transgenic mice, we found a
severely reduced number of endocrine precursor cells,
marked by ngn3 expression (Gradwohl et al., 2000;
Schwitzgebel et al., 2000), in or adjacent to ductal and
centroacinar cells marked by expression of mucin-1 (Figs.
6E–H). RT-PCR analysis underscored these findings as it
revealed that the overall expression level of ngn3 transcripts
is diminished (Fig. 6I). Therefore, deregulation of Hedge-hog signaling after pancreas morphogenesis has been
initiated results in rapid reduction of epithelial cells and
endocrine cell precursors. In contrast, pathway activation
leads to a marked expansion of mesenchymal cells.Discussion
Delayed activation of Hedgehog signaling blocks pancreas
development
Previous reports have shown that Hedgehog ligands are
excluded from pancreatic tissue at the onset of organ
development and forced activation of Hedgehog signaling
at these early stages is incompatible with proper organo-
genesis. In contrast, there is increasing evidence that
Hedgehog signaling components, including Ihh, Dhh, and
Ptch, are expressed during normal pancreas development
and in mature tissue (Fig. 5L; Supplementary Fig. 2)
Fig. 5. Early pancreatic defects in Pax4-Hh transgenic embryos at E15.5. Reduction in pancreas size of Pax4-Hh transgenic embryos is apparent in isolated
E15.5 pancreatic rudiments (A–C). Hematoxilin/eosin staining and morphometric analysis shows 87.3% and 84.9% reduction in epithelial area and 39.6% and
46.5% increase in mesenchymal tissue (D–F, G, K). Insulin and amylase expression was reduced in both of Pax4-Shh and -Ihh transgenic mice (H–J). The
Hedgehog transcriptional target Ptch is expressed at low levels in wt epithelium and found at higher levels in Pax4-Hh transgenic pancreas in epithelial as well
as mesenchymal cells (L–N). Blue dotted lines mark epithelial and epithelial-derived tissue; blue arrowheads mark mesenchymal tissue. wt, control; PS, Pax4-
Shh; PI, Pax4-Ihh. (G) Blue bar, control, n = 23; red bar, Pax4-Shh; n = 6; yellow bar, Pax4-Ihh, n = 13. (K) Blue bar, control, n = 4; red bar, Pax4-Shh, n = 4;
yellow bar, Pax4-Ihh, n = 4. Error bars are shown as SD. #No statistical difference; TP b 0.05; TTP b 0.01; TTTP b 0.001. Scale bar is 50 Am.
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addition, studies in insulinoma cell lines have demonstrated
that Hedgehog signaling activates Pdx-1 and insulin
promoter activity (Thomas et al., 2000, 2001) and that
treatment with cyclopamine, an inhibitor of Hedgehog
signaling (Cooper et al., 1998; Incardona et al., 1998),
blocks Pdx-1 promoter activity. Several possibilities could
explain these discrepancies. First, it is possible that Hedge-
hog signaling initially inhibits pancreas formation during
early stages of development until organ boundaries have
been established, and that it subsequently acquires a
different, positive role in maturing tissue. While we cannot
exclude that Hedgehog signaling is required for mature
endocrine functions in adult animals, our studies clearly
indicate that deregulation of the pathway even late during
development impairs proper organ growth. However, due to
the early lethality of embryos lacking all Hedgehog signal-
ing (Zhang et al., 2001), experiments designed to addressthe requirement of Hedgehog signaling during pancreas
development and functions will require temporal- and
spatial-specific gene inactivation.
A second possibility is that individual Hedgehog ligands
exert different effects during pancreas development. In
contrast to Ihh, Shh is not detected during pancreas
development and studies of homozygous mutant mice have
revealed different requirements for Shh and Ihh during
patterning of the enteric nervous system in the duodenum
(Ahlgren et al., 1997; Hebrok et al., 2000; Ramalho-Santos
et al., 2000). Individual Hedgehog ligands elicit similar
responses, albeit with different efficiencies, in various
biological assays (Pathi et al., 2001). To determine whether
the overall level of Hedgehog signaling or ligand-specific
activities affect organ development, we decided to express
Shh and Ihh under control of the same promoter in
pancreatic tissue. No statistically significant difference in
Hedgehog activation was observed in Pax4-Shh and Pax4-
Fig. 6. Decreased number of endocrine progenitor cells in E15.5 Pax4-Hh embryos. Insulin-positive cells were reduced by 78.3% and 84.5% in Pax4-Shh and
Pax4-Ihh pancreata. The reduction in glucagon-positive cells is less pronounced and not statistically significant in Pax4-Ihh embryos (A–D). Ngn3-positive
cells were identified along pancreatic ducts (yellow arrow head, E–G). The number of ngn3-positive cells was reduced to approximately 80% in both of Pax4-
Hh embryos (H). RT-PCR results indicate a reduction in ngn3 transcripts (I). wt, control; PS, Pax4-Shh; PI, Pax4-Ihh. (D) Blue bars, control, n = 3; red bars,
Pax4-Shh, n = 5; yellow bars, Pax4-Ihh, n = 5. (H) Blue bar, control, n = 3; red bar, Pax4-Shh; n = 4; yellow bar, Pax4-Ihh, n = 4. Error bars are shown as SD.
#No statistical difference; TP b 0.05; TTP b 0.01. Scale bar is 50 Am.
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types observed in Pax4-Shh and Pax4-Ihh mice were almost
identical with respect to the increase in mesenchymal tissue
and reduction of the exocrine, endocrine, and epithelial
progenitor cell compartments. Thus, our results argue that
the overall level of Hedgehog activation regulates pancreas
organogenesis independent of pathway induction by indi-
vidual ligands.
Hedgehog signaling regulates formation of pancreatic
epithelium and mesenchyme
Analysis of pancreas gross morphology at the end of
gestation revealed a significant reduction in pancreas mass,
due to depletion of exocrine and endocrine compartments.
These defects are reminiscent but less severe than those
observed in Pdx-Shh mice (Apelqvist et al., 1997). While
only remnants of pancreatic tissue are found dispersed in
duodenal tissue of Pdx-Shh mice, pancreatic tissue is clearly
visible and demarcated from adjacent organs upon delayed
activation of Hh signaling in Pax4-Hh mice (Figs. 2A–C).
The presence of unaffected adjacent organs may be
explained by the fact that the Pax4 promoter restricts target
gene expression to pancreatic epithelium during develop-
ment whereas Pdx-1 promoter expression is also found in
the caudal stomach and proximal duodenum (Offield et al.,
1996). Alternatively, the delayed induction of ligand
expression and the potentially lower level of Hedgehogactivity in Pax4-Hh mice could also limit the defects to the
pancreas proper.
It is interesting to note that pancreatic mesenchyme is
markedly increased in Pax4-Hh mice. A hallmark of
Hedgehog signaling is the ability to control cell differ-
entiation in a concentration-dependent manner. In Pdx-Shh
mice, pancreatic mesenchyme differentiates into duodenal
mesoderm (Apelqvist et al., 1997), indicating that the sharp
boundaries between Hedgehog-positive stomach and duo-
denum and Hedgehog-negative pancreas are essential for
proper patterning of the fore–midgut area. Our results
confirm these previous findings by demonstrating expres-
sion of a-smooth muscle actin (sma), a marker for duodenal
mesenchyme, in pancreatic tissue of Pax4-Shh or Pax4-Ihh
lines (Figs. 3D–F). These results point to a remarkable
plasticity of the pancreatic mesenchyme as ectopic Hedge-
hog signaling is activated in transgenic Pax4Hh lines
around E13, several days after the pancreatic mesenchyme
has condensed around the budding pancreatic epithelium
(~E10).
Pancreatic target cells of Hedgehog signaling
Transcriptional profiling experiments have shown that
Hedgehog signaling is active at low levels during develop-
ment but the identity of Hedgehog-responsive cell types
remains elusive (Hebrok, 2003; Kawahira et al., 2003).
Here, we provide evidence that mesodermal cells respond to
H. Kawahira et al. / Developmental Biology 280 (2005) 111–121120Hedgehog signaling by induction of Hedgehog target genes
(Figs. 5L–N, Supplementary Figs. 2G–I). These results
support earlier studies that noted increased Ptch expression
in pancreatic mesenchyme of notochord-deleted chick
embryos (Hebrok et al., 1998). Our results also support
the notion that pancreatic epithelial cells directly respond to
Hedgehog signaling. The expression of Ptch in epithelial
and epithelial-derived endocrine cell clusters in wild type
embryos (Fig. 5L, Supplementary Fig. 2G) is reminiscent of
the expression in mature pancreas in which duct and islet
structures are Hedgehog-responsive tissues (Hebrok et al.,
2000; Thomas et al., 2000). Increased Hedgehog target
expression in epithelial and epithelial-derived endocrine
cells of Pax4-Hh transgenic mice suggests that pathway
activation may directly affect proliferation of these cells.
However, we cannot exclude that the Hedgehog-induced
transdifferentiation of pancreatic mesenchyme towards
duodenal mesoderm results in the release of additional
signals that prohibit proper differentiation of the epithelial
layer along the pancreatic differentiation path.
Hedgehog signaling controls epithelial cell expansion
Forced misexpression of Shh throughout pancreas
development under the control of the Pdx-1 promoter
results in impaired formation of islet clusters. Here, we
show that ectopic expression of either Shh or Ihh midway
through development leads to a significant reduction of
epithelial cells, including ngn3-positive endocrine precur-
sors and epithelial-derived insulin- and glucagon-expressing
cells (Figs. 4, 6). During normal development, both insulin
and ngn3-positive cells appear in large numbers during the
secondary transition around E13, the time point when
ectopic expression of Hh genes is first observed in Pax4-
Hh transgenic embryos (Fig. 1). In contrast, glucagon-
positive cells are abundant even before this stage. It is
interesting to note that in the transgenic mice, the numbers
of both insulin and ngn3-positive cells are reduced by a
similar margin (~80% reduction) while the loss of glucagon-
positive cells is less severe (40–60% reduction in Pax4-Ihh
and Pax4-Shh, respectively). These results argue that
elevation of Hedgehog activity preferentially affects devel-
oping rather than differentiated cells. This hypothesis is
supported by the observation that those cells that express
insulin at E18.5 appear to be fully differentiated as they
express mature h-cell markers (Fig. 4). On the other hand,
h-cells in Pax4-Hh transgenic pancreas are impaired in their
proliferation capacity, suggesting that improper Hedgehog
activation may also affect expansion of differentiated cells.
Enlarged duct cells in Pax4-Hh transgenic embryos
Elevated Hedgehog signaling in Pdx-Shh transgenic
mice has recently been shown to initiate changes in ductal
cell morphology similar to stage 1–2 neoplastic pancreatic
intraepithelial lesions (PanIN) commonly observed duringneoplastic transformation in pancreatic adenocarcinoma
(Hruban et al., 2001; Thayer et al., 2003). In Pax4-Hh
transgenic embryos, we observed impaired architecture of
the ductal system (Figs. 3G–I, data not shown). However,
pathological analysis revealed that these changes were still
within the normal morphological spectrum, suggesting that
the short time of increased Hedgehog activity from E13.0
to E18.5 was insufficient to promote neoplastic trans-
formation. Furthermore, ductal cells reverted to normal
morphology in Pax4-Hh mice after birth, a process that
could be explained by the loss of Pax4-promoter activity in
non-islet clusters of the maturing pancreas (Smith et al.,
2000). These results reveal the astounding plasticity of
pancreatic duct cells to respond to varying concentrations
of Hedgehog signaling and further suggest that pathway
elevation above a certain threshold is sufficient to initiate
changes in ductal cell morphology. Future experiments will
have to address whether adult duct cells normally respond
to elevated levels of Hedgehog activity by initiating a
neoplastic response.Acknowledgments
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